Harel Insurance Investments & Financial Services Ltd. trimmed its position in DocuSign by 12.3% during the third quarter, disposing of 10,530 shares to hold 75,416 shares valued at $5.428 million by period end. Other institutional moves include NewEdge Advisors LLC boosting its stake by 36.4% to 9,202 shares ($749,000), MassMutual Private Wealth & Trust FSB adding 31.3% to 595 shares ($46,000), Mn Services Vermogensbeheer B.V. growing by 1.1% to 74,900 shares ($5.834 million), IFM Investors Pty Ltd increasing 5.5% to 36,401 shares ($2.835 million), and Perpetual Ltd raising its holding 30.4% to 10,635 shares ($828,000). Institutions now account for 77.64% of DocuSign’s outstanding stock.

Royal Bank of Canada lowered its target from $95 to $70 and maintained a sector perform rating; Piper Sandler cut its price objective from $90 to $75 with a neutral stance; Bank of America reduced its target from $102 to $82, also neutral; Wells Fargo & Company trimmed its objective from $85 to $75 with an equal weight rating. Cantor Fitzgerald reaffirmed an outperform rating. In total, six analysts rate DocuSign as Buy and sixteen as Hold, yielding a consensus Hold rating and an average target of $85.13.

Director Robert Chatwani sold 13,818 shares at an average price of $68.33, raising $944,184 and reducing his stake by 16.45% to 70,197 shares valued at $4.796 million. CEO Allan C. Thygesen disposed of 26,250 shares at $69.60, generating $1.827 million and cutting his holding by 15.58% to 142,261 shares worth $9.901 million. Combined insider sales totaled 78,292 shares for proceeds of $5.374 million over the last three months, with insiders now holding 1.01% of the company’s shares.